Sexual desire and the female sexual function index
(FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in wmen with and without hypoactive sexual desire disorder.
The Female Sexual Function Index
(FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function.
Evaluation of female sexual function index
and associated factors among married women in North Eastern Black Sea region of Turkey.
Critical flaws in the Female Sexual Function Index
and the International Index of Erectile Function.
The present study was conducted to evaluate the prevalence and the potential risk factors of FSD across a selection of social groups in Beijing, China, based on the Female Sexual Function Index
Our patient's preoperative female sexual function index
was found to be 23; and that of postoperative was found 33.
Changes in Female Sexual Function Index
(FSFI) scores from baseline to study's end were 0.24 in the 316 women in the placebo group, compared with 0.54 in the 314 women in the study drug arm of the first study (P less than .0002).
Therefore, in this study, we aimed to evaluate the sexual function of female patients with pSS in comparison to healthy females by using the Female Sexual Function Index
Female sexual function index
(FSFI) was assessed at 30-35 days.
Eligible women were requested to complete a demographic questionnaire and female sexual function index
(FSFI), while one of the researchers (SY) attended if women had any ambiguity in questions.
Female Sexual Function Index
(FSFI) is used for assessing sexual function in women using 6 domains and 19 items.
The women had to score lower than 26 on the Female Sexual Function Index
(FSFI) and lower than 11 on the Female Sexual Distress Scale (FSDS) and demonstrate one more of the following female sexual dysfunction (FSD) issues: hypoactive sexual desire disorder (HSDD), female sexual arousal disorder (FSAD), female orgasmic disorder (FOD), or combined genital and subjective arousal disorder.